Jackson Square Partners’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-3,519,199
Closed -$283M 98
2021
Q2
$283M Sell
3,519,199
-105,419
-3% -$8.03M 1.62% 23
2021
Q1
$246M Sell
3,624,618
-1,023,489
-22% -$80.4M 1.4% 28
2020
Q4
$324M Buy
4,648,107
+1,348,325
+41% +$83.9M 1.29% 33
2020
Q3
$170M Buy
3,299,782
+1,247,824
+61% +$68.5M 0.79% 39
2020
Q2
$120M Sell
2,051,958
-1,496,965
-42% -$82.8M 0.6% 50
2020
Q1
$180M Sell
3,548,923
-21,186
-0.6% -$1.41M 1.13% 31
2019
Q4
$264M Buy
3,570,109
+190,506
+6% +$11.9M 1.39% 26
2019
Q3
$193M Buy
3,379,603
+679,851
+25% +$45.1M 1.06% 33
2019
Q2
$177M Buy
2,699,752
+962,468
+55% +$67M 0.91% 36
2019
Q1
$129M Buy
+1,737,284
New +$122M 0.7% 40

Other funds holding HQY

Jackson Square Partners's HQY Position: Q3 2021 in Review

Jackson Square Partners sold out of HealthEquity (HQY) in Q3 2021, closing a stake of 3,519,199 shares — an estimated $283M sold.

Jackson Square Partners first reported a position in HQY in Q1 2019 and held it in 10 quarters. The position peaked at $324M in Q4 2020. 286 funds tracked by Wall St. Rank hold HQY as of Q3 2021.

  • Jackson Square Partners reported no remaining HealthEquity position as of Q3 2021 after selling out during the quarter.
  • Jackson Square Partners sold 3,519,199 HealthEquity shares in Q3 2021, an estimated $283M.
  • Jackson Square Partners first reported a position in HealthEquity in Q1 2019 and held it in 10 quarters.
  • Jackson Square Partners's HealthEquity position peaked at $324M in Q4 2020.
  • 286 funds tracked by Wall St. Rank held HealthEquity as of Q3 2021.

Based on Jackson Square Partners's 13F filing for Q3 2021, filed 12 Nov 2021.